GE HealthCare Technologies Inc (GEHC) concluded trading on Thursday at a closing price of $81.45, with 3.6 million shares of worth about $293.55 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -4.79% during that period and on March 13, 2025 the price saw a loss of about -2.79%. Currently the company’s common shares owned by public are about 456.96M shares, out of which, 456.08M shares are available for trading.
Stock saw a price change of -4.64% in past 5 days and over the past one month there was a price change of -6.41%. Year-to-date (YTD), GEHC shares are showing a performance of 4.18% which decreased to -12.42% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $74.51 but also hit the highest price of $94.80 during that period. The average intraday trading volume for GE HealthCare Technologies Inc shares is 3.04 million. The stock is currently trading -7.79% below its 20-day simple moving average (SMA20), while that difference is down -6.02% for SMA50 and it goes to -3.35% lower than SMA200.
GE HealthCare Technologies Inc (NASDAQ: GEHC) currently have 456.96M outstanding shares and institutions hold larger chunk of about 85.66% of that.
The stock has a current market capitalization of $37.25B and its 3Y-monthly beta is at 1.23. PE ratio of stock for trailing 12 months is 18.76, while it has posted earnings per share of $4.34 in the same period. Its PEG reads 2.01 and has Quick Ratio of 0.79 while making debt-to-equity ratio of 1.11. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for GEHC, volatility over the week remained 3.41% while standing at 2.77% over the month.
Stock’s fiscal year EPS is expected to rise by 4.80% while it is estimated to increase by 11.69% in next year. EPS is likely to grow at an annualized rate of 9.31% for next 5-years, compared to annual growth of 5.31% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Goldman on March 11, 2025 offering a Buy rating for the stock and assigned a target price range of between $85 and $100 to it. Coverage by Jefferies stated GE HealthCare Technologies Inc (GEHC) stock as a Buy in their note to investors on January 08, 2025, suggesting a price target of $103 for the stock. On September 26, 2024, UBS Downgrade their recommendations, while on September 18, 2024, BTIG Research Upgrade their ratings for the stock with a price target of $100. Stock get a Neutral rating from JP Morgan on September 09, 2024.
